Nakatani D, Dohi T, Hikoso S, Tanaka A, et al. Relationship between Canagliflozin, Sodium Glucose Cotransporter 2 Inhibitor, and Hematopoietic Effects in Patients with Diabetes and Mild Heart Failure: Results from the CANDLE trial. J Cardiovasc Pharmacol 2023 Apr 18. doi: 10.1097/FJC.0000000000001430.
PMID: 37070931